SNPS — what changed in the latest 10-Q
A section-by-section comparison of SNPS's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-27 vs the prior 10-Q · 2026-02-25
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +61 | −58 | ~17 | 24 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~3 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | Text added/removed | +4 | −2 | 0 | 1 |
| Risk factors | Text added/removed | +16 | −17 | ~23 | 132 |
| Other information | Text added/removed | 0 | −4 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-27
For the second quarter of fiscal 2026, our results reflect continued, strong execution and the resiliency of our business, including 42% revenue growth compared to the second quarter of fiscal 2025, primarily due to strength across our business and Ansys' contribution of $652.4 million in revenue, p…
Net income from continuing operations attributed to Synopsys$17.1 $349.2 $82.1 $644.9
Net loss from discontinued operations attributed to Synopsys
Financial performance summary for the three months ended April 30, 2026 compared to the same period of fiscal 2025:
•Revenues were $2.3 billion, an increase of $671.7 million or 42%, which includes revenues from Ansys of $652.4 million. The remaining growth came organically due to strength across our business, partially offset by weakness in our Design IP segment.
Text removed vs the prior filing · source: 10-Q · 2026-02-25
For the first quarter of fiscal 2026, our results reflect continued, strong execution and the resiliency of our business, including 66% revenue growth compared to the first quarter of fiscal 2025, primarily due to revenue growth across a majority of product groups and geographies and Ansys' contribu…
Diluted net income per share attributed to Synopsys:$0.34 $1.89
Financial performance summary for the three months ended January 31, 2026 compared to the same period of fiscal 2025:
•Revenues were $2.4 billion, an increase of $953.5 million or 66%, which includes revenues from Ansys of $885.6 million. The remaining growth came organically across a majority of products and geographies, offset by weakness in our Design IP segment.
•Total cost of revenue and operating expenses was $2.2 billion, an increase of $1.0 billion or 83%, reflecting $394.1 million of amortization expense related to intangible assets acquired from the Ansys Merger, as well as an increase of $350.2 million in employee-related costs primarily due to the h…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-05-27
We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. On October 31, 2025, a shareholder class action complaint was filed in the United States District Court for the Northern District of California captioned…
In addition, on December 22, 2025, a shareholder derivative action was filed in the United States District Court for the Northern District of California captioned Brian Taylor v. Aart De Geus, et al. (Case No. 5:25-cv-10878) against certain of our directors and officers (the Taylor Action). The comp…
The parties have stipulated that the Class Actions are related cases, and the Derivative Actions have been stayed pending resolution of any motion to dismiss that will be filed in the related Class Actions. The parties have stipulated to consolidate the Derivative Actions, forming the action caption…
We regularly review the status of each significant matter and assess the potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain…
Text removed vs the prior filing · source: 10-Q · 2026-02-25
We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. On October 31, 2025, a shareholder class action complaint was filed in the United States District Court for the Northern District of California captioned…
We regularly review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain…
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-27
Our global operations are subject to numerous U.S. and foreign laws and regulations such as those related to anti-corruption, tax, corporate governance, imports and exports, government contracts, economic sanctions, financial and other disclosures, privacy and labor relations. These laws and regulat…
obligations to be imposed by these laws and regulations, and we may be required to make significant changes in our business operations, all of which may adversely affect our revenues and our business overall. Any violation of these laws, regulations and requirements could subject us to, among other …
Our Ansys business distributes its products through a global network of independent channel partners. Difficulties in ongoing relationships with channel partners, such as failure to meet performance criteria, differences in handling customer relationships or the loss of a major channel partner, coul…
Our stock price has been, and may continue to be, volatile, which may make it more difficult for our stockholders to sell their shares at a time or a price that is favorable to them. Such volatility has attracted, and may in the future attract, securities litigation and activist stockholders seeking…
increase costs, or result in loss of customer confidence and damage to our reputation, any of which could adversely affect our business and our ability to sell our products and services.
Text removed vs the prior filing · source: 10-Q · 2026-02-25
Our global operations are subject to numerous U.S. and foreign laws and regulations such as those related to anti-corruption, tax, corporate governance, imports and exports, government contracts, economic sanctions, financial and other disclosures, privacy and labor relations. These laws and regulat…
things, investigations, fines, enforcement actions, disgorgement of profits, damages, civil or criminal penalties, or injunctions, and may result in our inability to conduct business in one or more countries. Furthermore, any violation individually or in the aggregate could have a material adverse e…
Our Ansys business distributes its products through a global network of independent channel partners. Difficulties in
ongoing relationships with channel partners, such as failure to meet performance criteria, differences in handling
customer relationships or the loss of a major channel partner, could adversely affect the performance of our Ansys
Other information
Text removed vs the prior filing · source: 10-Q · 2026-02-25
Aggregate Number of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement
(1)Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the Rule).
(2)Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only p…
(4)For additional details about the material terms of this arrangement, refer to the description under the heading "Insider Adoption or Termination of Trading Arrangements" contained in Part II, Item 9B, Other Information of our Annual Report on Form 10-K for the year ended October 31, 2024, which i…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice